
Description
Adrenocortical carcinoma (ACC) is a rare and deadly disease that affects 0.5-2 people per million per year in the US. Currently, the first line clinical management includes surgical resection, followed by treatment with the chemotherapeutic agent mitotane. These interventions, however, have limited effectiveness, as the overall five-year survival rate of patients with ACC is less than 35%.
Download count: 0
Details
Contributors
- Razzaghi, Raud (Author)
- Wilson-Rawls, Jeanne (Thesis director)
- Anderson, Karen (Committee member)
- Katja, Kiseljak-Vassiliades (Committee member)
- School of Molecular Sciences (Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2016-12
Subjects
Resource Type
Collections this item is in